How medical education and health system characteristics affect care for Alzheimer's patients.

The effect of medical school, residency program, and health system board characteristics on AD/ADRD care quality and outcomes.

['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11092868

This study is looking at how different medical schools and health systems affect the care and outcomes for patients with Alzheimer's and related dementias, especially focusing on whether there are differences in treatment for patients from different racial and ethnic backgrounds, with the hope of finding ways to improve care for everyone.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded)
Locations1 site (LOS ANGELES, UNITED STATES)
Trial IDNIH-11092868 on ClinicalTrials.gov

What this research studies

This research investigates how the characteristics of medical schools, residency programs, and health system boards influence the quality of care and outcomes for patients with Alzheimer's disease and related dementias (AD/ADRD). By analyzing data from various national databases, the study aims to identify disparities in care received by racial and ethnic minority patients compared to their White counterparts. The research will utilize quasi-experimental methods to explore the impact of diversity in medical education and health system leadership on these disparities. Ultimately, the goal is to develop interventions that can improve care quality and reduce inequities in AD/ADRD treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research include patients diagnosed with Alzheimer's disease or related dementias, especially those from racial and ethnic minority backgrounds.

Not a fit: Patients who do not have Alzheimer's disease or related dementias are unlikely to benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved care quality and outcomes for patients with Alzheimer's disease and related dementias, particularly among racial and ethnic minority groups.

How similar studies have performed: Previous research has indicated that addressing disparities in healthcare can lead to improved patient outcomes, suggesting that this approach has potential for success.

Where this research is happening

LOS ANGELES, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.